Literature DB >> 12713626

Microvessel densities and microvascular architecture in colorectal carcinomas and their liver metastases: significant correlation of high microvessel densities with better survival.

F Prall1, U Gringmuth, H Nizze, M Barten.   

Abstract

AIMS: Microvessel densities in cancers have been shown to be a prognostic factor for some types of cancer. For colorectal cancer, however, the situation is far from clear.
METHODS: A consecutive series of 173 colorectal carcinomas was investigated, and to these were added 55 liver metastases originating from colorectal cancer. Microvessels were counted in hotspots (factor VIII immunostaining, 0.74 mm2). The capillary architecture was scored according to the degree of order and envelopment of the neoplastic glands. Endothelial proliferation was determined by factor VIII/Ki67 double labelling.
RESULTS: Mean microvessel densities were 51.8 for colorectal carcinomas (range 8-140) and 31.9 for liver metastases (range 3-101). Stratification according to stage, depth of infiltration and nodal involvement showed a significant inverse relation with increase. Mean microvessel densities in primaries were significantly higher than in metastases. Kaplan-Meier analysis showed a significantly higher cancer-specific survival for high microvessel densities (median as cut-off) and for a more ordered microvascular architecture. Endothelial proliferation in carcinomas was significantly higher than in normal mucosa.
CONCLUSIONS: Contrary to other types of cancer, for colorectal cancer high microvessel densities confer good rather than poor prognosis. We hypothesize that neoangiogenesis, though extant in colorectal cancer, is not rate-limiting in the metastatic cascade.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12713626     DOI: 10.1046/j.1365-2559.2003.01610.x

Source DB:  PubMed          Journal:  Histopathology        ISSN: 0309-0167            Impact factor:   5.087


  13 in total

1.  Immunohistochemical analysis of vascular density and area in colorectal carcinoma using different markers and comparison with clinicopathologic prognostic factors.

Authors:  Luciana Regina Moreira; André Almeida Schenka; Paulo Latuf-Filho; André Lisboa Penná; Carmen S P Lima; Fernando Augusto Soares; Miriam Aparecida Silva Trevisan; José Vassallo
Journal:  Tumour Biol       Date:  2011-01-08

2.  The clinical value of von Willebrand factor in colorectal carcinomas.

Authors:  Vera S Schellerer; Larissa Mueller-Bergh; Susanne Merkel; Robert Zimmermann; Dominik Weiss; Anne Schlabrakowski; Elisabeth Naschberger; Michael Stürzl; Werner Hohenberger; Roland S Croner
Journal:  Am J Transl Res       Date:  2011-09-23       Impact factor: 4.060

3.  Microvessel density and VEGF expression are prognostic factors in colorectal cancer. Meta-analysis of the literature.

Authors:  G Des Guetz; B Uzzan; P Nicolas; M Cucherat; J-F Morere; R Benamouzig; J-L Breau; G-Y Perret
Journal:  Br J Cancer       Date:  2006-06-19       Impact factor: 7.640

4.  Microvascular density and hypoxia-inducible factor pathway in pancreatic endocrine tumours: negative correlation of microvascular density and VEGF expression with tumour progression.

Authors:  A Couvelard; D O'Toole; H Turley; R Leek; A Sauvanet; C Degott; P Ruszniewski; J Belghiti; A L Harris; K Gatter; F Pezzella
Journal:  Br J Cancer       Date:  2005-01-17       Impact factor: 7.640

5.  The influence of invasive growth pattern and microvessel density on prognosis in colorectal cancer and colorectal liver metastases.

Authors:  R Rajaganeshan; R Prasad; P J Guillou; C R Chalmers; N Scott; R Sarkar; G Poston; D G Jayne
Journal:  Br J Cancer       Date:  2007-03-13       Impact factor: 7.640

6.  Prognostic Significance of Microvessel Density Determining by Endoglin in Stage II Rectal Carcinoma: A Retrospective Analysis.

Authors:  Zeljko Martinovic; Drazen Kovac; Mia Martinovic
Journal:  Gastroenterol Res Pract       Date:  2015-05-21       Impact factor: 2.260

7.  Expression of follicle-stimulating hormone receptor by the vascular endothelium in tumor metastases.

Authors:  Ahsan Siraj; Virginie Desestret; Martine Antoine; Gaëlle Fromont; Michel Huerre; Marc Sanson; Philippe Camparo; Christophe Pichon; François Planeix; Julie Gonin; Aurelian Radu; Nicolae Ghinea
Journal:  BMC Cancer       Date:  2013-05-20       Impact factor: 4.430

8.  Breast adenocarcinoma liver metastases, in contrast to colorectal cancer liver metastases, display a non-angiogenic growth pattern that preserves the stroma and lacks hypoxia.

Authors:  F Stessels; G Van den Eynden; I Van der Auwera; R Salgado; E Van den Heuvel; A L Harris; D G Jackson; C G Colpaert; E A van Marck; L Y Dirix; P B Vermeulen
Journal:  Br J Cancer       Date:  2004-04-05       Impact factor: 7.640

9.  The clinical implication of cancer-associated microvasculature and fibroblast in advanced colorectal cancer patients with synchronous or metachronous metastases.

Authors:  Yoonjin Kwak; Hee Eun Lee; Woo Ho Kim; Duck-Woo Kim; Sung-Bum Kang; Hye Seung Lee
Journal:  PLoS One       Date:  2014-03-18       Impact factor: 3.240

10.  Assessment of vascular endothelial growth factor in formalin fixed, paraffin embedded colon cancer specimens by means of a well-based reverse phase protein array.

Authors:  Joon-Yong Chung; Till Braunschweig; Seung-Mo Hong; David S Kwon; Soo-Heang Eo; HyungJun Cho; Stephen M Hewitt
Journal:  Proteome Sci       Date:  2014-05-13       Impact factor: 2.480

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.